跳转至内容
Merck
CN
  • Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Cancer cell (2018-12-07)
Christopher J Ott, Alexander J Federation, Logan S Schwartz, Siddha Kasar, Josephine L Klitgaard, Romina Lenci, Qiyuan Li, Matthew Lawlor, Stacey M Fernandes, Amanda Souza, Donald Polaski, Deepti Gadi, Matthew L Freedman, Jennifer R Brown, James E Bradner
摘要

Enhancer profiling is a powerful approach for discovering cis-regulatory elements that define the core transcriptional regulatory circuits of normal and malignant cells. Gene control through enhancer activity is often dominated by a subset of lineage-specific transcription factors. By integrating measures of chromatin accessibility and enrichment for H3K27 acetylation, we have generated regulatory landscapes of chronic lymphocytic leukemia (CLL) samples and representative cell lines. With super enhancer-based modeling of regulatory circuits and assessments of transcription factor dependencies, we discover that the essential super enhancer factor PAX5 dominates CLL regulatory nodes and is essential for CLL cell survival. Targeting enhancer signaling via BET bromodomain inhibition disrupts super enhancer-dependent gene expression with selective effects on CLL core regulatory circuitry, conferring potent anti-tumor activity.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
抗 α-微管蛋白单克隆抗体 小鼠抗, ascites fluid, clone B-5-1-2
Supelco
1,25-二羟基维生素 D3-13C3 (25,26,27-13C3)标准液 CRM 溶液, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®